RANI

NASDAQStock

Rani Therapeutics Holdings, Inc.

$1.32+0.04 (+2.71%)

52-Week Range

$0.41

$2.85

Key Stats

Market Cap

96.7M

P/E Ratio

—

Dividend Yield

—

Beta

0.41

Volume

554.0K

Avg Volume

887.0K

Performance

+3.20%

-11.03%

+164.40%

YTD

-5.15%

-14.57%

-78.32%

-88.27%

Price Chart

ETF Exposure

RANI is held by 11 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.02%	194,124	$266K	$1.27B	0.60%
SBIO.L	Invesco NASDAQ Biotech UCITS ETF	0.01%	0	$0	$416.2M	0.40%
IBBQ	Invesco Nasdaq Biotechnology ETF	0.01%	5,458	$7K	$72.1M	0.19%
BIB	ProShares - Ultra Nasdaq Biotechnology	0.01%	4,380	$6K	$86.8M	1.19%
VXF	Vanguard Extended Market ETF	0.00%	837,970	$1.0M	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	182	$298	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	6,504	$11K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	31	$51	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	3,703,205	$4.5M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	19,478	$32K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	1,679	$3K	$1.29B	0.17%

About RANI ETF Exposure

Rani Therapeutics Holdings, Inc. (RANI) is held by 11 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 96.7M, RANI is a widely held institutional stock. The stock currently trades at $1.32. Investors can gain exposure to RANI through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RANI, sorted by portfolio weight.